Filing Details
- Accession Number:
- 0001104659-20-122611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 17:43:48
- Reporting Period:
- 2020-11-05
- Accepted Time:
- 2020-11-06 17:43:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1356576 | Supernus Pharmaceuticals Inc. | SUPN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219844 | S Gregory Patrick | C/O Supernus Pharmaceuticals, Inc. 9715 Key West Avenue Rockville MD 20850 | Sr. Vp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-05 | 5,000 | $12.98 | 49,463 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-05 | 5,000 | $23.00 | 44,463 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-11-05 | 5,000 | $0.00 | 5,000 | $12.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,000 | 2026-03-01 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020.
- The option vests in four equal annual installments beginning on March 1, 2017.